Pioneer of outsourced sterilisation of reusable medical devices since 2001, Sterience consolidated the market in 2017 through Vanguard Medical Services (France's second largest player) acquisition. The Group has 12 centers in France and employs more than 300 people. Every year, it processes more than one million medical devices on behalf of about sixty health establishments (public or private) and instrumentation manufacturers. A key player in the medical chain, the Group was renamed Apperton in September 2019.
Investment date : 2015
Investment type : IBO